In Association with National Society of Regenerative Medicine

Call (561) 221-2000

×
  • Home
  • Open Studies
    • Sexual Dysfunction – Gurnee Illinois
    • Sexual Dysfunction – Denver Colorado
    • Hair Regeneration Study – San Francisco
    • Chronic Lateral Epicondylitis and/or Medial Epicondylitis Study – Jupiter, FL
    • Hair Regeneration Study – Oakbrook Terrace, IL
    • Screening Center for Atherosclerosis – Florida
    • Lumbar Spinal Stenosis Study – Boca Raton, FL
    • Knee Osteoarthritis – Danvers, MA
    • Knee Osteoarthritis – Oakbrook Terrace, IL
  • Research Centers
  • Become a Partner
  • Publications
  • Contact

Stem cell delivery of therapies for brain disorders

July 12, 2017

The blood brain barrier (BBB) poses a problem to deliver drugs for brain malignancies and neurodegenerative
disorders. Stem cells such as neural stem cells (NSCs) and mesenchymal stem cells (MSCs) can be used to delivery
drugs or RNA to the brain. This use of methods to bypass the hurdles of delivering drugs across the BBB is
particularly important for diseases with poor prognosis such as glioblastoma multiforme (GBM). Stem cell treatment
to deliver drugs to neural tumors is currently in clinical trial. This method, albeit in the early phase, could be an
advantage because stem cells can cross the BBB into the brain. MSCs are particularly interesting because to date,
the experimental and clinical evidence showed ‘no alarm signal’ with regards to safety. Additionally, MSCs do not
form tumors as other more primitive stem cells such as embryonic stem cells. More importantly, MSCs showed
pathotropism by migrating to sites of tissue insult. Due to the ability of MSCs to be transplanted across allogeneic
barrier, drug-engineered MSCs can be available as off-the-shelf cells for rapid transplantation. This review discusses
the advantages and disadvantages of stem cells to deliver prodrugs, genes and RNA to treat neural disorders.

Brain Injury Treatment Aleynik2014

Add Comment Cancel


Recent Posts

  • Cellular therapy with human autologous adipose-derived adult cells of stromal vascular fraction for alopecia areata
  • In vivo clinical and radiological effects of platelet-rich plasma on interstitial supraspinatus lesion: Case series
  • Current Therapeutic Strategies for Stem Cell-Based Cartilage Regeneration
  • Treatment of chronic low back pain – new approaches on the horizon
  • Current Perspectives regarding Stem Cell-Based Therapy for Alzheimer’s Disease

Archives

  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • July 2017

Categories

  • Adipose Tissue
  • Alopecia
  • Amniotic Allograft
  • Atherosclerosis
  • Back Pain
  • Bone Marrow
  • COPD
  • Crohn’s Disease
  • Degenerative Joint Disease
  • Diabetes
  • ED
  • Elbow Pain
  • Facial Rejuvenation
  • Hair Restoration
  • Hearing Loss
  • Ischemic Stroke
  • Knee Osteoarthritis
  • Lateral Epicondylitis
  • Lupus
  • Medial Epicondylitis
  • Mesenchymal Stem Cells
  • Migraines
  • Multiple Sclerosis
  • Non Healing Wounds
  • Osteoarthritis
  • Platelet Rich Plasma – PRP
  • Publications
  • Rotator Cuff
  • Sexual Dysfunction
  • Skin Diseases
  • Skin Rejuvenation
  • Stem Cells
  • Tendons and Ligaments
  • Traumatic Brain Injury
  • Umbilical Cord
  • Urinary Incontinence
  • Wharton’s Jelly

(561) 221-2000

info@clinicalstudyresearch.com

141 NW 20th Street, Boca Raton, FL 33431

Copyright ©2018 All Rights Reserved.
Designed by NWOL